D
Britannia Life Sciences Inc. BLAB
CNSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Revenue -- 1.24M 1.43M 1.29M 1.28M
Total Other Revenue -- -- -- -- --
Total Revenue -- 1.24M 1.43M 1.29M 1.28M
Cost of Revenue -- 518.20K 468.40K 419.10K --
Gross Profit -- 723.40K 965.40K 871.60K --
SG&A Expenses -- 845.60K 548.60K 751.80K --
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses -- 1.36M 1.02M 1.17M 1.04M
Operating Income -- -122.20K 416.80K 119.80K 244.10K
Income Before Tax -- -24.10K -685.50K -499.20K --
Income Tax Expenses -- 43.60K 108.00K -9.10K --
Earnings from Continuing Operations -- -67.70K -793.50K -490.10K --
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -30.10K -82.30K -49.30K --
Net Income -- -97.80K -875.80K -539.40K -4.38M
EBIT -- -122.20K 416.80K 119.80K 244.10K
EBITDA -- -102.90K 435.10K 137.10K 247.90K
EPS Basic 0.00 0.00 -0.01 0.00 -0.03
Normalized Basic EPS -- 0.00 0.00 0.00 --
EPS Diluted 0.00 0.00 -0.01 0.00 -0.03
Normalized Diluted EPS -- 0.00 0.00 0.00 --
Average Basic Shares Outstanding 162.25M 162.25M 162.25M 162.25M 162.25M
Average Diluted Shares Outstanding 162.25M 162.25M 162.25M 162.25M 162.25M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --